Vertex Pharmaceuticals IncorporatedEquity-NMS: VRTX
Equity-NMS: VRTX
$466.63
-3.38
(2 Dec)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$466.63
Open
$466.63
Today’s high
$468.19
Today’s low
$463.05
52W low
$347.51
52W high
$519.88
1Y
32.68%
5Y
16.13%
EPS (TTM)
-1.90
Shares O/S
257.53M
Market cap
120.17B
Insights
VRTX price is above its 200 day moving average
VRTX PE is in the low end of its range over the past 2 years
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on investing in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has four approved medicines that treat the underlying cause of cystic fibrosis (CF), and one approved therapy that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT).

Its pipeline includes clinical-stage programs in CF, SCD, TDT, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Its marketed medicines are TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). It is developing non-autologous (allogeneic) fully differentiated, stem-cell derived islet cell therapies designed to replace insulin-producing islet cells that are destroyed in people with T1D. .


FAQs

Can I buy Vertex Pharmaceuticals Incorporated shares in India?
How to buy Vertex Pharmaceuticals Incorporated shares in India?
What is the share price of Vertex Pharmaceuticals Incorporated?
What is the Market Capitalization of Vertex Pharmaceuticals Incorporated?
What is the PE ratio of Vertex Pharmaceuticals Incorporated?
Is Vertex Pharmaceuticals Incorporated a good stock to buy?
In which sector / industry does Vertex Pharmaceuticals Incorporated operate?